MOLECULAR PHARMACEUTICS

Molecular Pharmaceutics is a prestigious monthly peer-reviewed journal published by the American Chemical Society in the United States, dedicated to advancing the field of molecular pharmaceutics. With an ISSN of 1543-8384, the publication serves as a leading venue for high-impact research at the intersection of chemistry, biology, and medicine, focusing on critical areas such as molecular-level drug design, novel delivery systems, pharmacokinetics, targeted therapies, and nanomedicine. Recognized for its rigorous editorial standards and strong academic reputation, the journal is indexed in the Science Citation Index (SCI) and consistently ranks in the top tiers of the Chinese Academy of Sciences journal classification, often securing a Zone 1 or Zone 2 position in the pharmacology and pharmacy categories. While it operates as a hybrid publication offering partial open-access options rather than being fully open access, it remains a highly competitive outlet where high rejection rates reflect the demand for innovative, high-quality scientific contributions. Consequently, Molecular Pharmaceutics stands as an essential resource for researchers and professionals seeking to disseminate groundbreaking advancements in the molecular understanding and application of pharmaceutical sciences.